Peptide record

TPDB77551

Agouti-related prote Blood-Brain Barrier modified_plain modified
54 amino acids
Basic Information
TPDB77551
Agouti-related prote
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A 54-aa modified blood-brain barrier peptide sequence curated from Peptipedia, without an available 3D structural model.
C-terminal: Amidation C-terminal: Chemical modification Chemical: Cys5-Cys20, Cys12-Cys26, Cys19-Cys37, Cys23-Cys47, N-terminal: C-terminal modification
Sequence
SSRRCVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT-NH2
Physicochemical Analysis
C245H384N80O71S11
IW
C
5938.90
8.32
9
2
14
+5
5.80
-0.274
37.96
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
3605
60.70
24
Residue Composition
number
3
A
6
R
3
N
1
D
10
C
1
E
2
Q
2
G
2
H
0
I
3
L
1
K
1
M
3
F
3
P
4
S
3
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 3 R: 6 N: 3 D: 1 C: 10 E: 1 Q: 2 G: 2 H: 2 I: 0 L: 3 K: 1 M: 1 F: 3 P: 3 S: 4 T: 3 W: 0 Y: 2 V: 2
Chemical Descriptors
54
C245H384N80O71S11
5938.90
8.32
+5
5.80
-0.274
Chemical modification
Cys5-Cys20, Cys12-Cys26, Cys19-Cys37, Cys23-Cys47,
Linear
C-terminal modification
Similarity
Ser-Ser-Arg-Arg-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Met-Asn-Pro-Cys-Ser-Arg-Thr-NH2
Evidence Records 7 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.03136 ml/g

Assay & Model

Capillary depletion
Origin/Source
Capillary depletion (brain/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
0.00455 ml/g

Assay & Model

Capillary depletion
Origin/Source
Capillary depletion (capillary/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
0.02682 ml/g

Assay & Model

Capillary depletion
Origin/Source
Capillary depletion (parenchyma/serum)

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
83%

Assay & Model

Capillary depletion
Origin/Source
% parenchyma

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
81 min

Assay & Model

HPLC
Origin/Source
half life, serum

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 6 Activity

Activity

Blood-Brain Barrier
289 min

Assay & Model

HPLC
Origin/Source
half life, brain

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 7 Activity

Activity

Blood-Brain Barrier
0.000057 mL/(g x min)

Assay & Model

Origin/Source
Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Additional Detail Fields 1 fields
Intravenous